1. Home
  2. GPCR vs AHCO Comparison

GPCR vs AHCO Comparison

Compare GPCR & AHCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GPCR
  • AHCO
  • Stock Information
  • Founded
  • GPCR 2016
  • AHCO 2012
  • Country
  • GPCR United States
  • AHCO United States
  • Employees
  • GPCR N/A
  • AHCO N/A
  • Industry
  • GPCR
  • AHCO Medical/Nursing Services
  • Sector
  • GPCR
  • AHCO Health Care
  • Exchange
  • GPCR Nasdaq
  • AHCO Nasdaq
  • Market Cap
  • GPCR 1.1B
  • AHCO 1.2B
  • IPO Year
  • GPCR 2023
  • AHCO N/A
  • Fundamental
  • Price
  • GPCR $23.82
  • AHCO $8.90
  • Analyst Decision
  • GPCR Strong Buy
  • AHCO Strong Buy
  • Analyst Count
  • GPCR 9
  • AHCO 5
  • Target Price
  • GPCR $77.50
  • AHCO $13.40
  • AVG Volume (30 Days)
  • GPCR 1.1M
  • AHCO 1.9M
  • Earning Date
  • GPCR 05-08-2025
  • AHCO 05-06-2025
  • Dividend Yield
  • GPCR N/A
  • AHCO N/A
  • EPS Growth
  • GPCR N/A
  • AHCO N/A
  • EPS
  • GPCR N/A
  • AHCO 0.58
  • Revenue
  • GPCR N/A
  • AHCO $3,246,360,000.00
  • Revenue This Year
  • GPCR N/A
  • AHCO $1.72
  • Revenue Next Year
  • GPCR N/A
  • AHCO $4.61
  • P/E Ratio
  • GPCR N/A
  • AHCO $15.47
  • Revenue Growth
  • GPCR N/A
  • AHCO N/A
  • 52 Week Low
  • GPCR $13.22
  • AHCO $7.11
  • 52 Week High
  • GPCR $62.74
  • AHCO $11.90
  • Technical
  • Relative Strength Index (RSI)
  • GPCR 51.16
  • AHCO 51.98
  • Support Level
  • GPCR $25.06
  • AHCO $7.95
  • Resistance Level
  • GPCR $27.50
  • AHCO $9.20
  • Average True Range (ATR)
  • GPCR 1.86
  • AHCO 0.43
  • MACD
  • GPCR -0.31
  • AHCO 0.14
  • Stochastic Oscillator
  • GPCR 28.77
  • AHCO 76.98

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

About AHCO AdaptHealth Corp.

AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. It focuses on providing; sleep therapy equipment, supplies, and related services (including CPAP and bi-PAP services) to individuals suffering from obstructive sleep apnea (OSA), medical devices and supplies to patients for the treatment of diabetes (including continuous glucose monitors (CGM and insulin pumps), home medical equipment to patients discharged from acute care and other facilities, oxygen and related chronic therapy services in the home, and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy and nutritional supply needs.

Share on Social Networks: